Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

ATOS

ATOS News

Newswire

08:20

Atossa Therapeutics details accelerated FDA strategy for (Z)-Endoxifen breast cancer drug.

08:04

Insilico Medicine and Atossa Therapeutics Unveil AI-Driven Study Identifying (Z)-Endoxifen as Promising Glioblastoma Therapeutic Candidate

09:21

Atossa Therapeutics' (Z)-endoxifen shows potential in Duchenne Muscular Dystrophy treatment.

09:11

Atossa Therapeutics Highlights Potential of (Z)-Endoxifen in Treating Duchenne Muscular Dystrophy and Carrier-Associated Pathologies.

08:46

Atossa Therapeutics reports Q3 financial results, plans IND for (Z)-endoxifen in mBC.

View More

About ATOS

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More